176 related articles for article (PubMed ID: 677861)
1. In vitro studies of piperacilin, a new semisynthetic penicillin.
Winston DJ; Wang D; Young LS; Martin WJ; Hewitt WL
Antimicrob Agents Chemother; 1978 Jun; 13(6):944-50. PubMed ID: 677861
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of the anaerobic bacteria, group D streptococci, Enterobacteriaceae, and Pseudomonas to semisynthetic penicillins: carbenicillin, piperacillin, and ticarcillin.
Monif GR; Clark PR; Shuster JJ; Baer H
Antimicrob Agents Chemother; 1978 Nov; 14(5):643-9. PubMed ID: 103491
[TBL] [Abstract][Full Text] [Related]
3. Piperacillin, a new penicillin active against many bacteria resistant to other penicillins.
Fu KP; Neu HC
Antimicrob Agents Chemother; 1978 Mar; 13(3):358-67. PubMed ID: 122519
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro appraisal of piperacillin, including its activity against Salmonella typhi.
Robinson RG; Saunders J; Cassel R; Block CS; Koornhof HJ
Antimicrob Agents Chemother; 1980 Oct; 18(4):493-501. PubMed ID: 6449903
[TBL] [Abstract][Full Text] [Related]
5. Piperacillin: in vitro evaluation.
Bodey GP; Le Blanc B
Antimicrob Agents Chemother; 1978 Jul; 14(1):78-87. PubMed ID: 28694
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae.
Shah PP; Briedis DJ; Robson HG; Conterato JP
Antimicrob Agents Chemother; 1979 Mar; 15(3):346-50. PubMed ID: 111609
[TBL] [Abstract][Full Text] [Related]
7. Netilmicin: its in vitro activity and synergism with penicillin compounds.
Thadepalli H; Roy I
Chemotherapy; 1980; 26(1):12-20. PubMed ID: 7353438
[TBL] [Abstract][Full Text] [Related]
8. Piperacillin (T-1220), a new semisynthetic penicillin. II. In vitro antimicrobial activity and synergy comparison with carbenicillin and gentamicin.
Jones RN; Packer RR; Barry AL; Badal RE; Thornsberry C; Baker C
J Antibiot (Tokyo); 1979 Jan; 32(1):29-35. PubMed ID: 761991
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
George WL; Lewis RP; Meyer RD
Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
[TBL] [Abstract][Full Text] [Related]
10. Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
Reimer LG; Mirrett S; Reller LB
Antimicrob Agents Chemother; 1980 Mar; 17(3):412-6. PubMed ID: 6448577
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of pseudomonas to four beta-lactamantibiotics (ampicillin, cephalothin, carbenicillin, piperacillin), to four aminoglycosides (kanamycin, amikacin, gentamicin, tobramycin) and to colimycin.
Hoogkamp-Korstanje JA; Westerdaal NA
Chemotherapy; 1979; 25(1):48-53. PubMed ID: 253637
[TBL] [Abstract][Full Text] [Related]
12. Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.
Jones RN; Thornsberry C; Barry AL; Fuchs PC; Gavan TL; Gerlach EH
J Antibiot (Tokyo); 1977 Dec; 30(12):1107-14. PubMed ID: 599084
[TBL] [Abstract][Full Text] [Related]
13. Mezlocillin: in vitro studies of a new broad-spectrum penicillin.
Bodey GP; Pan T
Antimicrob Agents Chemother; 1977 Jan; 11(1):74-9. PubMed ID: 836016
[TBL] [Abstract][Full Text] [Related]
14. Mezlocillin: a new acyl ureidopenicillin. Antimicrobial activity and combination effects with four aminoglycoside antibiotics.
Schassan HH; Koperski K; Scherf H
Chemotherapy; 1978; 24(3):134-42. PubMed ID: 95925
[TBL] [Abstract][Full Text] [Related]
15. Activity of three aminoglycosides and two penicillins against four species of gram-negative bacilli.
Weinstein RJ; Young LS; Hewitt WL
Antimicrob Agents Chemother; 1975 Feb; 7(2):172-8. PubMed ID: 1137369
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of furazlocillin (Bay k 4999) compared with those of mezlocillin, piperacillin, and standard beta-lactam antibiotics.
Gootz TD; Sanders CC; Sanders WE
Antimicrob Agents Chemother; 1979 Jun; 15(6):783-91. PubMed ID: 475364
[TBL] [Abstract][Full Text] [Related]
17. CI-867, a new semisynthetic penicillin: in vitro studies.
Weaver SS; Bodey GP
Antimicrob Agents Chemother; 1980 Dec; 18(6):939-43. PubMed ID: 7235679
[TBL] [Abstract][Full Text] [Related]
18. Azlocillin: in vitro studies of a new semisynthetic penicillin.
Stewart D; Bodey GP
Antimicrob Agents Chemother; 1977 May; 11(5):865-70. PubMed ID: 18083
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of LY127935.
Barza M; Tally FP; Jacobus NV; Gorbach SL
Antimicrob Agents Chemother; 1979 Sep; 16(3):287-92. PubMed ID: 507785
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the in vitro activity of Bay k 4999 and piperacillin, two new antipseudomonal broad-spectrum penicillins, with other beta-lactam drugs.
Wise R; Andrews JM; Bedford KA
Antimicrob Agents Chemother; 1978 Oct; 14(4):549-52. PubMed ID: 102245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
